Australia markets open in 7 hours 57 minutes

IDEX Biometrics ASA (IDBA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
9.460.00 (0.00%)
As of 03:43PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 132.04M
Enterprise value 123.67M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)31.14
Price/book (mrq)8.80
Enterprise value/revenue 32.44
Enterprise value/EBITDA -3.63

Trading information

Stock price history

Beta (5Y monthly) 2.30
52-week change 3-67.62%
S&P500 52-week change 3-11.32%
52-week high 331.62
52-week low 34.60
50-day moving average 36.60
200-day moving average 39.91

Share statistics

Avg vol (3-month) 31.42k
Avg vol (10-day) 32.63k
Shares outstanding 514.9M
Implied shares outstanding 6N/A
Float 811.53M
% held by insiders 12.69%
% held by institutions 10.03%
Shares short (14 Nov 2022) 4142
Short ratio (14 Nov 2022) 40.14
Short % of float (14 Nov 2022) 4N/A
Short % of shares outstanding (14 Nov 2022) 40.00%
Shares short (prior month 13 Oct 2022) 41.44k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-877.62%

Management effectiveness

Return on assets (ttm)-104.68%
Return on equity (ttm)-219.07%

Income statement

Revenue (ttm)3.81M
Revenue per share (ttm)0.30
Quarterly revenue growth (yoy)26.80%
Gross profit (ttm)1.59M
EBITDA -32.5M
Net income avi to common (ttm)-36.71M
Diluted EPS (ttm)-2.62
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.06M
Total cash per share (mrq)0.67
Total debt (mrq)696k
Total debt/equity (mrq)4.67
Current ratio (mrq)4.07
Book value per share (mrq)1.12

Cash flow statement

Operating cash flow (ttm)-32.36M
Levered free cash flow (ttm)-17.84M